终末期与遗忘型轻度认知障碍患者的[18F]氟美他莫淀粉样蛋白区域摄取模式差异研究
本研究比较了180例终末期(含痴呆与非痴呆)患者与232例遗忘型轻度认知障碍(aMCI)患者的[18F]氟美他莫PET图像视觉判读区域阳性模式。结果显示两组阳性图像均以五个脑区广泛沉积为主,aMCI组视觉判读与SUVR定量一致率为95.3%,终末期尸检组为90.4%,提示aMCI患者已处于阿尔茨海默病连续谱中。
要点
- aMCI患者与终末期患者的区域淀粉样蛋白沉积模式相似,多呈五区广泛阳性。
- 视觉判读与SUVR定量在aMCI组一致率95.3%,尸检组90.4%。
- 观察淀粉样蛋白沉积早期征象应关注更早期人群如主观认知下降。
核心结论
- aMCI患者经视觉判读和SUVR确定的淀粉样蛋白分布与尸检证实的痴呆及非痴呆终末期患者相似。
- 多数aMCI患者已处于AD连续谱中,淀粉样蛋白沉积在量和拓扑进展上均呈广泛分布。
研究设计与样本
- 研究纳入180例终末期患者(平均年龄81岁,范围59-95岁)和232例aMCI患者(平均年龄71岁,范围53-91岁)。
- 静脉注射185-370 MBq [18F]氟美他莫后行PET扫描,由两组各5名盲法读片者独立判读五个脑区阳性或阴性。
- 以至少3/5读片者的多数意见作为影像终点,并与预设阈值的复合SUVR分析比较。
主要发现
- 终末期患者中71/106例尸检证实的淀粉样蛋白阳性图像被纳入分析,其中76%五个区域均阳性,另20%四个区域阳性。
- aMCI患者中97例淀粉样蛋白阳性图像被纳入,其中87%五个区域阳性,另5%四个区域阳性。
- 阳性判读图像的平均SUVR在尸检组为2.24(范围1.48-3.14),在aMCI组为2.08(范围1.28-3.04)。
- 视觉判读与SUVR定量的一致率在aMCI组为95.3%,在尸检组为90.4%。
临床怎么用
- 对于aMCI患者,[18F]氟美他莫PET视觉判读若显示多脑区阳性,提示已存在广泛淀粉样蛋白沉积,符合AD连续谱表现。
- 视觉判读与SUVR定量一致性高,支持视觉判读在aMCI评估中的可靠性。
- 若需探测淀粉样蛋白沉积的早期征象,应转向主观认知下降或临床前阶段人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Visual interpretation of PET [18F]flutemetamol images relies on systematic review of five brain regions and is considered positive when an elevated signal is observed in at least one region. Amnestic mild cognitive impairment (aMCI) is an early clinical presentation of Alzheimer's disease (AD); hence it is of interest to determine if the pattern of visually read regional positivity between end-of-life (EoL) patients with and without dementia and aMCI patients is different. METHODS: A total of 180 EoL patients with and without dementia (mean age 81 years, range 59 to 95 years) and 232 aMCI patients (mean age 71 years, range 53 to 91 years) were scanned following intravenous administration of 185-370 MBq [18F]flutemetamol. Images from both studies were read by two groups of five blinded readers who independently classified each of the five regions as either positive or negative. The majority interpretation made by at least three of the five readers was used as the imaging endpoint and compared with a composite standardized uptake value ratio (SUVR) analysis using a predetermined threshold. RESULTS: Amyloid-positive images from 71 of 106 EoL patients coming to autopsy and from 97 aMCI patients were included. In the images from the EoL patients widespread deposition of amyloid was observed, with 76% of the images positive in all five regions and a further 20% positive in four regions. In the images from the aMCI patients, similar results were observed with 87% of the images positive in five regions and a further 5% positive in four regions. The mean SUVR of these positively read images was 2.24 (range 1.48 to 3.14) and 2.08 (range 1.28 to 3.04) in the autopsy and aMCI groups, respectively. There was 95.3% agreement between the visual reading and SUVR quantitation in the aMCI group and 90.4% agreement in the autopsy group. CONCLUSION: Patients with aMCI showed a similar distribution of amyloid deposition determined by both visual reading and SUVR to that observed in patients with and without dementia coming to autopsy. Most of the aMCI patients, who are already within the AD continuum, had widespread amyloid deposition in terms of amount and topographical progression. Attempts to observe potential initial signs of amyloid deposition should focus on populations earlier in the dementia spectrum such as patients with subjective cognitive decline or even at-risk subjects with earlier stages of disease.
引用
- Farrar G, Molinuevo JL, Zanette M, et al. Is there a difference in regional read [18F]flutemetamol amyloid patterns between end-of-life subjects and those with amnestic mild cognitive impairment? Eur J Nucl Med Mol Imaging. 2019. PMID: 30863934. doi:10.1007/s00259-019-04282-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。